Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 4/2016

01-12-2016 | Case Report

Pancreatic Tumor Presenting as Diarrhea

Authors: Kalpit Devani, Dhara Chaudhari, Mark Young

Published in: Journal of Gastrointestinal Cancer | Issue 4/2016

Login to get access

Excerpt

VIPoma, Verner-Morrison syndrome, is a rare functioning neuroendocrine tumor that secretes vasoactive intestinal polypeptide (VIP). It is also known as pancreatic cholera or WDHA syndrome (watery diarrhea, hypokalemia and hypo or achlorhydria). Verner and Morrison first described the symptoms of VIPoma in 1958 as watery diarrhea, hypokalemia and achlorhydria [1]. Approximately 90 % of cases arise from the pancreas but they may also occur in periganglionic tissue or other locations such as the adrenals, colon, bronchus, liver and sympathetic ganglia. VIPomas are found to be malignant in about 60–80 % cases and are metastatic at the time of diagnosis, with the liver being the most common site of metastasis [2]. Herein, we present a patient with chronic diarrhea who was found to have VIPoma and did well after surgical resection. …
Literature
1.
go back to reference Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med. 1958;25(3):374–80.CrossRefPubMed Verner JV, Morrison AB. Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia. Am J Med. 1958;25(3):374–80.CrossRefPubMed
2.
go back to reference Abu-Zaid A, Azzam A, Abudan Z, et al. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male. Hematol Oncol Stem Cell Ther. 2014;7:109–15.CrossRefPubMed Abu-Zaid A, Azzam A, Abudan Z, et al. Sporadic pancreatic vasoactive intestinal peptide-producing tumor (VIPoma) in a 47-year-old male. Hematol Oncol Stem Cell Ther. 2014;7:109–15.CrossRefPubMed
3.
go back to reference Ghaferi AA, Chojnacki KA, Long WD, et al. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg. 2008;12:382–93.CrossRefPubMed Ghaferi AA, Chojnacki KA, Long WD, et al. Pancreatic VIPomas: subject review and one institutional experience. J Gastrointest Surg. 2008;12:382–93.CrossRefPubMed
5.
go back to reference Johnson JB, Marsden L, Samadder NJ. A rare cause of diarrhea: pancreatic VIPoma. Endoscopy. 2013;45(Suppl 2 UCTN):E311–2.PubMed Johnson JB, Marsden L, Samadder NJ. A rare cause of diarrhea: pancreatic VIPoma. Endoscopy. 2013;45(Suppl 2 UCTN):E311–2.PubMed
6.
go back to reference King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol. 1994;49(5):295–303.CrossRefPubMed King CM, Reznek RH, Dacie JE, Wass JA. Imaging islet cell tumours. Clin Radiol. 1994;49(5):295–303.CrossRefPubMed
7.
go back to reference Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology. 2000;214(2):483–90.CrossRefPubMed Thoeni RF, Mueller-Lisse UG, Chan R, Do NK, Shyn PB. Detection of small functional islet cell tumors in the pancreas: selection of MR imaging sequences for optimal sensitivity. Radiology. 2000;214(2):483–90.CrossRefPubMed
8.
go back to reference Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395.CrossRefPubMedPubMedCentral Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395.CrossRefPubMedPubMedCentral
9.
go back to reference Strosberg JR, Cheema A, Weber JM, et al. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications. Ann Surg. 2012;256:321.CrossRefPubMed Strosberg JR, Cheema A, Weber JM, et al. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications. Ann Surg. 2012;256:321.CrossRefPubMed
10.
go back to reference Strosberg JR, Cheema A, Weber J, et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol. 2011;29:3044.CrossRefPubMed Strosberg JR, Cheema A, Weber J, et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol. 2011;29:3044.CrossRefPubMed
11.
go back to reference Roland CL, Bian A, Mansour JC, et al. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. J Surg Oncol. 2012;105:595.CrossRefPubMed Roland CL, Bian A, Mansour JC, et al. Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypes. J Surg Oncol. 2012;105:595.CrossRefPubMed
12.
go back to reference Bilimoria KY, Bentrem DJ, Merkow RP, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007;205:558.CrossRefPubMed Bilimoria KY, Bentrem DJ, Merkow RP, et al. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors. J Am Coll Surg. 2007;205:558.CrossRefPubMed
Metadata
Title
Pancreatic Tumor Presenting as Diarrhea
Authors
Kalpit Devani
Dhara Chaudhari
Mark Young
Publication date
01-12-2016
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 4/2016
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-015-9770-8

Other articles of this Issue 4/2016

Journal of Gastrointestinal Cancer 4/2016 Go to the issue